Clinical Trials Browser

Phase 1 × darolutamide × 30 days × Clear all

Urogenital Diseases, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT05999968 2026-03-05

Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment

Phase 1 Completed

10 enrolled

Genitourinary

Prostatic Neoplasms

NCT05617885 2026-02-27

Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

Phase 1 Active not recruiting

9 enrolled

Genitourinary

Prostatic Neoplasms

NCT05938270 2026-02-24

ASCERTAIN

Phase 1 Recruiting

120 enrolled

Genitourinary

Prostatic Neoplasms

NCT05997615 2026-02-24

AMX-500

Phase 1 Recruiting

390 enrolled

Genitourinary

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

Clinical Trials

STRIKE-001

Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment

Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

ASCERTAIN

AMX-500